Delivery Order SPE2DB20D3101-SPE2DB24FRTU1

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,224.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,796,218 units of Cetirizine HCL 10 mg tablets, with a completion date of April 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,680.23, is for the delivery of 4,567,781,423 units of Cetirizine HCL 10 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.90, is a delivery order for the supply of Cetirizine HCL 10 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,002.44 firm fixed-price delivery order is for the supply of 4,564,462,943 units of Cetirizine HCl 10 mg tablets. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The federal contract award is for the delivery of 4,567,154 units of Cetirizine HCL 5 mg tablets in 100-count packages. The contract, valued at $1,121.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price pricing type and a completion date of February 5, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,168.23, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,967.72 firm-fixed-price contract is for the delivery of 4,567,520,514 units of Cetirizine HCl 5 mg tablets to support military healthcare programs. The contract has a period of performance through March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $7,709.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601,125 units of Cetirizine Hydrochloride 10 mg tablets, a generic pharmaceutical product used to treat allergies. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 26, 2023. It is not...
This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets in 100-count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,975.44. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of May 16, 2025. The contract is not set aside for any particular business type....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Cetirizine HCL 10 mg tablets. The contract has a ceiling value of $10,334.41 and is a Firm Fixed Price Delivery Order, with a period of performance through March 19, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRTU1
    Delivery Order

This federal contract award, valued at $2,498.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cetirizine HCL 5mg tablets, a generic allergy medication, to support military healthcare programs. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and no subcontractors are mentioned. This award demonstrates the company's role as a key vendor for the DLA, supporting the healthcare needs of military personnel and veterans through the efficient procurement of essential medical commodities.

Generated 2/27/25, 9:47 AM